Physicochemical Characteristics of Activated Biochar Derived from Different Sources

An experiment was carried out to study the characteristics of biochar made from rice husk, rice straw, Toria stover and bamboo leaves. Biochar was produced by slow pyrolysis system (300 –4000C). Locally available bio-wastes viz.rice husk, rice straw, toriastover and bamboo leaves were used as raw materials to produce chars. Two samples of feedstock each from 5 development blocks of Jorhat district of Assam were collected, dried and pyrolysed for production of char for their physicochemical properties. Per cent moisture and ash content, bulk density, particle density andporosity of biochars ranged from 3.26 to 4.91%, 3.70 to 24.97%, 0.178 to 0.729 g/cm3, 0.85 to 2.02 g/cm3 and 61.54 to 78.90%, respectively. Pore volume, particle size and specific surface area ranged from 0.83 to 1.15 ml, 310×147 to 350×209 ?m2 and 89.40 to 184.75 m2/g, whereas pH ,EC, CEC, total Carbon varied from 7.74 to 9.46, 0.272 to 1.005 dsm-1, 12.74 to16.68 c mol (p+)/kg and 36.63 to 49.424%, respectively. Porosity maintained significant and positive correlation with pore volume (0.715**) and specific surface area (0.614**). CEC had significant positive correlations with total C (0.583**), total N (0.587**), total K (0.443**) and IAN (0.766**).Percent total N, P, K, and S had their value ranged from 47.27 to 60.07, 0.017 to 0.032, 0.237 to 0.453 and 0.083 to 0.099; while, Ca and Mg, Fe, Zn, Cu and Iodine adsorption number ranged from 1.11 to 5.23 and 0.148 to 1.326 c mol (p+)/kg, 16.65 to 2.91, 30 to 162, 8.6 to 43 mg/kg and 186.64 to 489.77 mg/g of biochar

Comparison of tolterodine with standard treatment in pediatric patients with non-neurogenic dysfunctional voiding/over active bladder : A systematic review.

To examine the efficacy, safety and tolerability of tolterodine in children with overactive bladder in comparison with standard treatment i.e. oxybutynin as demonstrated in randomized clinical trials and other studies. A systematic search was done to screen the studies evaluating the effect of tolterodine in children with nonneurogenic overactive bladder. Results of studies were pooled and compared. Efficacy was determined from micturition diaries and dysfunctional voiding symptoms score. Safety and tolerability were assessed from the reported treatment emergent adverse events. A total of six randomized clinical trials and 11 other studies of tolterodine in children with urinary incontinence were included in the present systematic review. The dose of tolterodine used in different settings ranged from ‘0.5 to 8 mg/day’ instead of ‘0.5 to 8 mg/kg per day’ and the duration of studies ranged from 2 weeks to 12 months. Both extended and immediate release preparations of tolterodine were shown to have comparable efficacy and tolterodine proved to have comparable efficacy with better tolerability than oxybutynin in these studies. It can be concluded that tolterodine is efficacious in treatment of urinary incontinence in children. Moreover, its efficacy is comparable to oxybutynin, the most commonly prescribed anticholinergic in this condition, while having better tolerability. Hence, it can be considered as first line therapy for the treatment of urinary incontinence in children.

Effect of esomeprazole on pharmacokinetics of phenytoin in rabbits.

Esomeprazole is commonly prescribed proton pump inhibitor for gastritis and peptic ulcer disease. Most of the time in clinical practice, phenytoin and esomeprazole are prescribed for patients of generalized seizures with concomitant peptic ulcer. Hence there are chances of drugdrug interaction because of modulations of isoenzymes CYP2C9 and CYP2C19, are involved in metabolism of phenytoin and esomeprazole. But it is important to maintain the therapeutic level of phenytoin in plasma for effective seizures control. So, the aim of the study was to determine the effect of esomeprazole on the pharmacokinetics of phenytoin in rabbits. In a parallel design study, phenytoin, 30 mg/kg/day per oral was given daily for 14 days. On day 15, blood samples were taken at various time intervals between 0-24 hours. In esomeprazole-phenytoin group, phenytoin was administered for seven days as mentioned earlier and from day 8th onward, esomeprazole 2.8 mg/kg along with phenytoin 30 mg/kg/day was administered till 14th days and blood samples were drawn as above on 15th day. Plasma phenytoin levels were assayed by HPLC and pharmacokinetic parameters were calculated. In esomeprazole-phenytoin group, there was a significant increase of t½el than phenytoin alone group and significant increase in AUC0-24 was also observed in the esomeprazole and phenytoin treated group. These results suggest that esomeprazole alters the pharmacokinetics of phenytoin. Confirmation of these results in further clinical studies will warrant changes in phenytoin dose or frequency when esomeprazole is co-administered.

Comparative Clinical Trial of Paracetamol alone and Vitamin C and E as an Add on Therapy in Patients Suffering From Primary Knee Osteoarthritis.

A randomized observational blind comparative clinical study was conducted to compare the antioxidant effect of vitamin C and E with paracetamol in patients of primary knee osteoarthritis.Subjects presenting with sign, symptoms of primary knee osteoarthritis were given paracetamol 1 gm (n=50) twice daily for 8 weeks and combinations of paracetamol 1gm bid with vitamin C (500 mg ) and E (200 IU) (n=50) twice daily for 8 weeks. Subjects completed an over all evaluation of symptoms relief on 2nd, 4th and 8th weeks of completed treatment were evaluated by clinical, routine laboratory and radiographic investigations for improvement of disease conditions, also for adverse drug reaction. On completion of 8 weeks of treatment it was observed that both the treatment group patients showed significant efficacy with better results with patients receiving antioxidant therapy in primary knee osteoarthritis patients (p<0.001) and adverse drug reaction were minor and none of patients complain of any severe adverse drug reaction. Present study indicate that antioxidant therapy can be used as an effective add on therapy in primary knee osteoarthritis.

Effect of combination of thalidomide and sulfasalazine in experimentally induced inflammatory bowel disease in rats.

Thalidomide provided significant protection against tri nitro benzene sulfonic acid induced colitis. Combination therapy also reduced colonic inflammation and all the biochemical parameters (myeloperoxidase assay, malondialdehyde assay and tumor necrosis factor- , estimation) were significant as compared to control as well as thalidomide alone treated group. Combination therapy showed additive effect of thalidomide which restored lipid peroxidation as well as reduced myeloperoxidase and TNF- towards the normal levels. Morphological and histological scores were significantly reduced in combination groups. In experimental model of colitis, oral administration of thalidomide (150 mg/kg) alone as well as its combination with sulfasalazine (360 mg/kg) significantly reduced the colonic inflammation. The results indicate the additive effect of thalidomide with sulfasalazine in rat colitis model which requires further confirmation in human studies.

Topical Application of Honey in The Treatment of Wound Healing: A Metaanalysis.

Honey has been extensively studied in the treatment of wound but efficacy in clinical practice is not fully established. The aim of the present study was to evaluate the efficacy of topical application honey in observational studies as well as in controlled clinical trials in the treatment of wound healing. A systematic literature search was carried out from 1966 to 31 July 2008 in Pubmed, Medline, Embase, Cochrane database using the appropriate search key words. We found 5 observational studies with 160 patients while 963 cases in 10 controlled clinical trials where 511 patients were treated with honey. Efficacy was found highly efficacious in observational studies but in controlled clinical trial showed its modest efficacy. Most of the patients reported with complete healing of 99% within 2-9 weeks in observational and 56 % in controlled trials and healing was observed within 4-12 weeks time in controlled clinical trials however some of the recent double blind trial showed no superior benefit of honey compare to control. So base on above trials it can be concluded that topical application of honey is useful for the treatment for wound healing but to fully established its efficacy, larger prospective double blind study is required in near future.

Effect of Manuka honey and sulfasalazine in combination to promote antioxidant defense system in experimentally induced ulcerative colitis model in rats.

Manuka honey (MH, 5g/kg) provided protection against trinitro-benzo-sulphonic acid induced colonic damage. Combination therapy (MH+sulfasalazine) also reduced colonic inflammation and all the biochemical parameters were significant compared to control and MH alone treated group. Combination therapy showed additive effect of the MH which restored lipid peroxidation and improvement of antioxidant parameters. Morphological and histological scores were significantly reduced in combination groups. In inflammatory model of colitis, oral administration of MH (5g/kg) and combination with sulfasalazine (360 mg/kg) with MH (5g/kg) significantly reduced the colonic inflammation. The results indicate the additive effect of Manuka honey with sulfasalazine in colitis.

Effect of propofol in altering pentylenetetrazol induced seizure threshold in rats.

The present study was undertaken to evaluate the role of propofol in altering pentylenetetrazol induced seizure threshold in rats. Total 42 Wistar rats were used to evaluate different parameters (onset of action, duration of seizure, seizure severity score and number of seizure) following propofol injection. The present results showed that there was significant reduction in the time required for onset of seizure in propofol treated groups following PTZ treatment. If treated with propofol alone (2 and 5 mg/kg), there was no significant difference as compared to controls. In seizure severity score assessment, there was no significant difference with various doses of propofol alone treated groups, but the difference was observed in propofol (2 and 5 mg/kg) treated groups following PTZ treatment. Duration of seizure also significantly increased in propofol (5 mg/kg) treated group, but at 2 mg/kg of propofol treatment, no significant difference was observed. The present results showed that propofol ameliorate seizure threshold and caused prolongation of duration of seizure. However, further study and trials are needed to confirm the present results.

Genetic basis of HIV-1 resistance and susceptibility: an approach to understand correlation between human genes and HIV-1 infection.

HIV infection is the serious medical and public health issue of present generation. By 2005, it has already infected a cumulative total of more than sixty million people worldwide and the number of HIV positive cases are rising day by day. India is currently estimated to have about 5.1 million infected persons with HIV-1 or AIDS (second only to South Africa) and this number could increase to 24 million in the next ten years. This pandemic situation of the AIDS stimulated a plethora of longitudinal cohort studies which are designed to document medical heterogeneity as well as to mitigate the factors that regulate the HIV-1 infection, disease progression and the immune defenses. In recent years these genetic studies have led to the discovery of various MHC and non MHC encoded genes, which directly or indirectly influence the susceptibility and resistance to HIV infection and AIDS. These genes and their mutated forms and their products which play a major role in determining the susceptibility or resistance to HIV-1 infection and AIDS. These genes have been categorized into MHC or non MHC encoded genes. The MHC encoded genes which determine HIV resistance or susceptibility are HLA-B57, HLA-B58, HLA-B27, HLA-Bw4 and HLA-A11 in Southeast Asians. On the other hand, non MHC encoded genes are CCR5, CCR2, RANTES, CXCL12, CXCR6, CCL3L1, Interleukin-10 (IL-10), and interferon gamma. The site specific mutations in these genes determine the susceptibility or resistance to HIV-1 infection and AIDS. In future the study of host genes in relation to HIV-1 infection may provide the researchers to develop newer chemotherapeutic approaches to prevent or cure HIV-1 infection effectively.

Experimental Teaching and Interactive Computer Assisted Learning : The Student’s Viewpoint

A student view point regarding utility and present role of experimental teaching and interactive computer assisted learing was cited from three Medical Colleges of North India using a set of questionnaires. The majority of the student cited that animal experiments are important part of medical curriculum. However, computer assisted learning techniques will be useful aid in future but currently cannot replace animal experiments as the tool of choice for medical education and research.

Honey--a remedy rediscovered and its therapeutic utility.

Honey is a common household product with many medicinal uses described in traditional medicine. Modern system of medicine is also finding the honey efficacious in various medical and surgical conditions. Antimicrobial, antioxidant and wound healing properties of honey are being evaluated with successful outcome. Prevention and treatment of various infections due to a wide variety of organisms and promoting surgical wound healing are some of the areas where honey is making its mark.